Hunter Associates Investment Management LLC Pfizer Inc Transaction History

Hunter Associates Investment Management LLC

$674 Million
Q2 2025

A detailed history of Hunter Associates Investment Management LLC transactions in Pfizer Inc stock. As of the latest transaction made, Hunter Associates Investment Management LLC holds 121,147 shares of PFE stock, worth $3 Million. This represents 0.44% of its overall portfolio holdings.

Number of Shares

121,147

Previous 121,484 0.28%

Holding current value

$3 Million

Previous $3.08 Million 4.58%

% of portfolio

0.44%

Previous 0.47%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 05, 2025	SELL	$21.59 - $24.84 $7,275 - $8,371	-337 Reduced 0.28%	121,147 $2.94 Million
Q1 2025 Apr 30, 2025	SELL	$25.01 - $27.13 $12,304 - $13,347	-492 Reduced 0.4%	121,484 $3.08 Million
Q4 2024 Jan 23, 2025	SELL	$24.8 - $30.19 $342,140 - $416,501	-13,796 Reduced 10.16%	121,976 $3.24 Million
Q3 2024 Oct 24, 2024	SELL	$27.7 - $31.39 $17,367 - $19,681	-627 Reduced 0.46%	135,772 $3.93 Million
Q2 2024 Aug 01, 2024	SELL	$25.26 - $29.6 $18,742 - $21,963	-742 Reduced 0.54%	136,399 $3.82 Million
Q1 2024 May 01, 2024	SELL	$25.89 - $29.73 $74,045 - $85,027	-2,860 Reduced 2.04%	137,141 $3.81 Million
Q4 2023 Jan 31, 2024	SELL	$26.13 - $33.94 $53,906 - $70,018	-2,063 Reduced 1.45%	140,001 $4.03 Million
Q3 2023 Nov 09, 2023	SELL	$32.09 - $37.51 $57,505 - $67,217	-1,792 Reduced 1.25%	142,064 $4.71 Million
Q2 2023 Aug 03, 2023	SELL	$36.12 - $41.79 $8,199 - $9,486	-227 Reduced 0.16%	143,856 $5.28 Million
Q1 2023 May 02, 2023	BUY	$39.39 - $51.28 $21,585 - $28,101	548 Added 0.38%	144,083 $5.88 Million
Q4 2022 Feb 01, 2023	SELL	$41.75 - $54.5 $40,581 - $52,974	-972 Reduced 0.67%	143,535 $7.35 Million
Q3 2022 Nov 02, 2022	SELL	$43.76 - $53.42 $1,006 - $1,228	-23 Reduced 0.02%	144,507 $6.33 Million
Q2 2022 Aug 10, 2022	BUY	$46.53 - $55.17 $1.25 Million - $1.48 Million	26,896 Added 22.86%	144,530 $7.58 Million
Q2 2021 Aug 05, 2021	SELL	$35.91 - $40.68 $1.3 Million - $1.47 Million	-36,183 Reduced 23.52%	117,634 $4.61 Million
Q1 2021 May 10, 2021	BUY	$33.49 - $37.77 $166,947 - $188,283	4,985 Added 3.35%	153,817 $5.57 Million
Q4 2020 Jan 29, 2021	SELL	$33.47 - $42.56 $6,426 - $8,171	-192 Reduced 0.13%	148,832 $5.48 Million
Q3 2020 Nov 10, 2020	SELL	$31.75 - $37.25 $25,209 - $29,576	-794 Reduced 0.53%	149,024 $5.47 Million
Q2 2020 Aug 13, 2020	SELL	$30.12 - $36.54 $5,542 - $6,723	-184 Reduced 0.12%	149,818 $4.9 Million
Q1 2020 May 11, 2020	BUY	$27.03 - $38.62 $19,785 - $28,269	732 Added 0.49%	150,002 $4.9 Million
Q4 2019 Feb 07, 2020	SELL	$32.92 - $37.36 $33,940 - $38,518	-1,031 Reduced 0.69%	149,270 $5.85 Million
Q3 2019 Nov 08, 2019	BUY	$32.49 - $42.13 $3,443 - $4,465	106 Added 0.07%	150,301 $5.4 Million
Q2 2019 Aug 08, 2019	SELL	$36.98 - $41.52 $10,909 - $12,248	-295 Reduced 0.2%	150,195 $6.51 Million
Q1 2019 May 10, 2019	SELL	$37.5 - $41.2 $22,312 - $24,514	-595 Reduced 0.39%	150,490 $6.39 Million
Q4 2018 Feb 11, 2019	SELL	$38.47 - $43.86 $97,559 - $111,228	-2,536 Reduced 1.65%	151,085 $6.6 Million
Q3 2018 Nov 09, 2018	SELL	$34.47 - $41.81 $6,721 - $8,152	-195 Reduced 0.13%	153,621 $6.77 Million
Q2 2018 Aug 10, 2018	SELL	$32.98 - $35.16 $49,733 - $53,021	-1,508 Reduced 0.97%	153,816 $5.58 Million
Q1 2018 May 15, 2018	BUY	$31.91 - $37.02 $48,024 - $55,715	1,505 Added 0.98%	155,324 $5.51 Million
Q1 2018 May 14, 2018	SELL	$31.91 - $37.02 $6,382 - $7,404	-200 Reduced 0.13%	153,819 $5.57 Million
Q4 2017 Feb 15, 2018	BUY	$33.26 - $35.29 $15,632 - $16,586	470 Added 0.31%	154,019 $5.58 Million
Q3 2017 Nov 13, 2017	BUY	$31.0 - $34.15 $4.76 Million - $5.24 Million	153,549	153,549 $5.48 Million

Others Institutions Holding PFE

# of Institutions

3,294

Shares Held

3.66B

Call Options Held

96.1M

Put Options Held

121M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $139B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hunter Associates Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hunter Associates Investment Management LLC with notifications on news.

Account

Hunter Associates Investment Management LLC Pfizer Inc Transaction History